JPMORGAN CHASE & CO - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 25 filers reported holding APTEVO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$629
-37.1%
1,907
+834.8%
0.00%
Q1 2022$1,000204
+2814.3%
0.00%
Q2 2020$07
-22.2%
0.00%
Q1 2020$090.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$39,477,0007.86%
RTW INVESTMENTS, LP 281,402$6,312,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 187,995$4,217,0000.09%
Anson Funds Management LP 35,587$798,0000.08%
Alyeska Investment Group, L.P. 139,172$3,122,0000.04%
Dynamic Technology Lab Private Ltd 14,022$315,0000.03%
JBF Capital, Inc. 3,907$88,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 15,350$344,0000.01%
Renaissance Technologies 159,923$3,587,0000.00%
QS Investors, LLC 15,650$352,0000.00%
View complete list of APTEVO THERAPEUTICS INC shareholders